rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Kare Schultz

Director

Company insider

Files Form 4 as: Director, Hims & Hers Health; President and CEO, Teva Pharmaceutical Industries; Director, International Flavors & Fragrances.

In numbers

Trades disclosed
61
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
3
Companies where not an officer
2
First trade
9 Feb 2018
Last trade
14 Aug 2026
Last filed
18 Aug 2026

Companies traded

Where they are an officer
TEVA Teva Pharmaceutical IndustriesDirector, Officer · Pharmaceuticals · last 1 Nov 20220 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
HIMS Hims & Hers HealthDirector · Digital Health & Telemedicine · last 14 Aug 20260 buys · 0 sells
IFF International Flavors & FragrancesDirector · Chemicals · last 5 May 20220 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
14 Aug 2026filed 18 Aug 2026HIMS Hims & Hers HealthDigital Health & TelemedicineSEC FORM 4 Code M—6,623filing
14 Aug 2026filed 18 Aug 2026HIMS Hims & Hers Healthoption or derivative · Digital Health & TelemedicineSEC FORM 4 Code M—6,623 at $0.00filing
14 Aug 2026filed 18 Aug 2026HIMS Hims & Hers Healthoption or derivative · Digital Health & TelemedicineSEC FORM 4 Code M—6,623 at $0.00filing
14 Aug 2026filed 18 Aug 2026HIMS Hims & Hers HealthDigital Health & TelemedicineSEC FORM 4 Code M—6,623filing
12 Aug 2026filed 14 Aug 2026HIMS Hims & Hers Healthoption or derivative · Digital Health & TelemedicineSEC FORM 4 Code A—8,223 at $0.00filing
12 Aug 2026filed 14 Aug 2026HIMS Hims & Hers Healthoption or derivative · Digital Health & TelemedicineSEC FORM 4 Code A—8,223 at $0.00filing
11 Jun 2026filed 15 Jun 2026HIMS Hims & Hers HealthDigital Health & TelemedicineSEC FORM 4 Code M—3,656filing
11 Jun 2026filed 15 Jun 2026HIMS Hims & Hers Healthoption or derivative · Digital Health & TelemedicineSEC FORM 4 Code M—3,656 at $0.00filing
11 Jun 2026filed 15 Jun 2026HIMS Hims & Hers Healthoption or derivative · Digital Health & TelemedicineSEC FORM 4 Code M—3,656 at $0.00filing
11 Jun 2026filed 15 Jun 2026HIMS Hims & Hers HealthDigital Health & TelemedicineSEC FORM 4 Code M—3,656filing
15 Sep 2025filed 17 Sep 2025HIMS Hims & Hers Healthoption or derivative · Digital Health & TelemedicineSEC FORM 4 Code M—6,623 at $0.00filing
15 Sep 2025filed 17 Sep 2025HIMS Hims & Hers HealthDigital Health & TelemedicineSEC FORM 4 Code M—6,623filing
6 Aug 2025filed 8 Aug 2025HIMS Hims & Hers Healthoption or derivative · Digital Health & TelemedicineSEC FORM 4 Code A—3,656 at $0.00filing
12 Jun 2025filed 16 Jun 2025HIMS Hims & Hers Healthoption or derivative · Digital Health & TelemedicineSEC FORM 4 Code M—9,118 at $0.00filing
12 Jun 2025filed 16 Jun 2025HIMS Hims & Hers HealthDigital Health & TelemedicineSEC FORM 4 Code M—9,118filing
7 Aug 2024filed 8 Aug 2024HIMS Hims & Hers Healthoption or derivative · Digital Health & TelemedicineSEC FORM 4 Code A—19,870 at $0.00filing
7 Aug 2024filed 8 Aug 2024HIMS Hims & Hers Healthoption or derivative · Digital Health & TelemedicineSEC FORM 4 Code A—9,118 at $0.00filing
1 Nov 2022filed 2 Nov 2022TEVA Teva Pharmaceutical Industriesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—116,389 at $0.00filing
1 Nov 2022filed 2 Nov 2022TEVA Teva Pharmaceutical IndustriesPharmaceuticalsSEC FORM 4 Code M—116,389filing
5 May 2022filed 6 May 2022IFF International Flavors & Fragrancesoption or derivative · ChemicalsSEC FORM 4 Code M—1,089 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Roberto MignoneDirector · Director at Teva Pharmaceutical Industries, filing Form 4 there in the last year
Brian SavageInterim Chief Legal Officer · Interim Chief Legal Officer at Teva Pharmaceutical Industries, filing Form 4 there in the last year
Ronit Satchi-FainaroDirector · Director at Teva Pharmaceutical Industries, filing Form 4 there in the last year
Amir WeissChief Accounting Officer · Chief Accounting Officer at Teva Pharmaceutical Industries, filing Form 4 there in the last year
Evan LippmanEVP, Business Development · EVP, Business Development at Teva Pharmaceutical Industries, filing Form 4 there in the last year